Published in Mov Disord on June 15, 2013
Recessive mutations in the α3 (VI) collagen gene COL6A3 cause early-onset isolated dystonia. Am J Hum Genet (2015) 1.66
The focal dystonias: current views and challenges for future research. Mov Disord (2013) 1.62
Dystonia as a network disorder: what is the role of the cerebellum? Neuroscience (2013) 1.20
A missense mutation in KCTD17 causes autosomal dominant myoclonus-dystonia. Am J Hum Genet (2015) 0.93
Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia. Prog Neurobiol (2015) 0.92
Diagnosis and treatment of dystonia. Neurol Clin (2015) 0.90
Recent advances in the genetics of dystonia. Curr Neurol Neurosci Rep (2014) 0.84
A rare sequence variant in intron 1 of THAP1 is associated with primary dystonia. Mol Genet Genomic Med (2014) 0.81
Dystonia: Five new things. Neurol Clin Pract (2015) 0.81
The New Classification System for the Dystonias: Why Was it Needed and How was it Developed? Mov Disord Clin Pract (2014) 0.80
Abnormalities of motor function, transcription and cerebellar structure in mouse models of THAP1 dystonia. Hum Mol Genet (2015) 0.78
Motor phenotypes and molecular networks associated with germline deficiency of Ciz1. Exp Neurol (2016) 0.76
Dystonia type 6 gene product Thap1: identification of a 50 kDa DNA-binding species in neuronal nuclear fractions. Acta Neuropathol Commun (2014) 0.76
Role of major and brain-specific Sgce isoforms in the pathogenesis of myoclonus-dystonia syndrome. Neurobiol Dis (2016) 0.75
The dystonias: past, present, and future. Mov Disord (2013) 0.75
Evolving concepts in the pathogenesis of dystonia. Parkinsonism Relat Disord (2017) 0.75
Towards a proteome-scale map of the human protein-protein interaction network. Nature (2005) 24.76
AAA+ proteins: have engine, will work. Nat Rev Mol Cell Biol (2005) 7.73
The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet (1997) 5.39
wishful thinking encodes a BMP type II receptor that regulates synaptic growth in Drosophila. Neuron (2002) 3.79
Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope. Neuron (2005) 3.75
Mutations in GNAL cause primary torsion dystonia. Nat Genet (2012) 3.66
Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet (1994) 3.39
DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA. Lancet Neurol (2008) 3.03
The BMP homolog Gbb provides a retrograde signal that regulates synaptic growth at the Drosophila neuromuscular junction. Neuron (2003) 2.86
Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome. Neuron (2005) 2.82
Mutations in the THAP1 gene are responsible for DYT6 primary torsion dystonia. Nat Genet (2009) 2.73
Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study. Lancet Neurol (2010) 2.60
Mutations in THAP1 (DYT6) in early-onset dystonia: a genetic screening study. Lancet Neurol (2009) 2.24
Mislocalization to the nuclear envelope: an effect of the dystonia-causing torsinA mutation. Proc Natl Acad Sci U S A (2004) 2.19
Muscular dystrophies and the dystrophin-glycoprotein complex. Curr Opin Neurol (1997) 2.13
TorsinA in the nuclear envelope. Proc Natl Acad Sci U S A (2004) 2.06
Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet (2001) 2.06
Here come the SUNs: a nucleocytoskeletal missing link. Trends Cell Biol (2006) 2.00
Mutations in the autoregulatory domain of β-tubulin 4a cause hereditary dystonia. Ann Neurol (2013) 1.90
THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies. Oncogene (2003) 1.89
The AAA+ protein torsinA interacts with a conserved domain present in LAP1 and a novel ER protein. J Cell Biol (2005) 1.89
The neural substrates of rapid-onset Dystonia-Parkinsonism. Nat Neurosci (2011) 1.87
Mutations in THAP1 (DYT6) and generalised dystonia with prominent spasmodic dysphonia: a genetic screening study. Lancet Neurol (2009) 1.86
The THAP domain of THAP1 is a large C2CH module with zinc-dependent sequence-specific DNA-binding activity. Proc Natl Acad Sci U S A (2005) 1.84
Mutations in CIZ1 cause adult onset primary cervical dystonia. Ann Neurol (2012) 1.82
The THAP-zinc finger protein THAP1 regulates endothelial cell proliferation through modulation of pRB/E2F cell-cycle target genes. Blood (2006) 1.81
TorsinA binds the KASH domain of nesprins and participates in linkage between nuclear envelope and cytoskeleton. J Cell Sci (2008) 1.80
Role of Gα(olf) in familial and sporadic adult-onset primary dystonia. Hum Mol Genet (2013) 1.79
Mutations in ANO3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesis. Am J Hum Genet (2012) 1.78
Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated DeltaE-torsinA mutant. Proc Natl Acad Sci U S A (2004) 1.78
Generation and characterization of Dyt1 DeltaGAG knock-in mouse as a model for early-onset dystonia. Exp Neurol (2005) 1.76
Mutant torsinA interferes with protein processing through the secretory pathway in DYT1 dystonia cells. Proc Natl Acad Sci U S A (2007) 1.73
Aberrant cellular behavior of mutant torsinA implicates nuclear envelope dysfunction in DYT1 dystonia. J Neurosci (2004) 1.71
Notch1 is required for neuronal and glial differentiation in the cerebellum. Development (2002) 1.69
Neuropathology of cervical dystonia. Exp Neurol (2012) 1.69
Structure-function analysis of the THAP zinc finger of THAP1, a large C2CH DNA-binding module linked to Rb/E2F pathways. J Biol Chem (2007) 1.62
Reduced neuron-specific expression of the TAF1 gene is associated with X-linked dystonia-parkinsonism. Am J Hum Genet (2007) 1.62
Primary dystonia and dystonia-plus syndromes: clinical characteristics, diagnosis, and pathogenesis. Lancet Neurol (2011) 1.62
Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia. J Clin Invest (2009) 1.60
Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients. J Neurol Neurosurg Psychiatry (2009) 1.46
Dystonia-causing mutant torsinA inhibits cell adhesion and neurite extension through interference with cytoskeletal dynamics. Neurobiol Dis (2005) 1.44
Phosphorylation on Thr-55 by TAF1 mediates degradation of p53: a role for TAF1 in cell G1 progression. Mol Cell (2004) 1.44
Decreased [18F]spiperone binding in putamen in idiopathic focal dystonia. J Neurosci (1997) 1.43
Transgenic mouse model of early-onset DYT1 dystonia. Hum Mol Genet (2004) 1.42
Dopamine release is impaired in a mouse model of DYT1 dystonia. J Neurochem (2007) 1.41
TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion. Neurobiol Dis (2003) 1.39
The dystonia gene DYT1 is repressed by the transcription factor THAP1 (DYT6). Ann Neurol (2010) 1.36
Effects of genetic variations in the dystonia protein torsinA: identification of polymorphism at residue 216 as protein modifier. Hum Mol Genet (2006) 1.35
Dystroglycan is selectively associated with inhibitory GABAergic synapses but is dispensable for their differentiation. J Neurosci (2002) 1.33
The cerebellum in dystonia - help or hindrance? Clin Neurophysiol (2011) 1.31
Direct interaction between causative genes of DYT1 and DYT6 primary dystonia. Ann Neurol (2010) 1.30
Dystonia in Parkinson's disease. J Neurol (2006) 1.30
Abnormal motor function and dopamine neurotransmission in DYT1 DeltaGAG transgenic mice. Exp Neurol (2008) 1.29
Chk2 molecular interaction map and rationale for Chk2 inhibitors. Clin Cancer Res (2006) 1.28
SGCE missense mutations that cause myoclonus-dystonia syndrome impair epsilon-sarcoglycan trafficking to the plasma membrane: modulation by ubiquitination and torsinA. Hum Mol Genet (2007) 1.28
THAP proteins target specific DNA sites through bipartite recognition of adjacent major and minor grooves. Nat Struct Mol Biol (2009) 1.27
Gene positioning and expression. Curr Opin Cell Biol (2011) 1.26
Dystonia-associated mutations cause premature degradation of torsinA protein and cell-type-specific mislocalization to the nuclear envelope. Hum Mol Genet (2008) 1.25
Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia. Neurobiol Dis (2006) 1.25
The dystonia-associated protein torsinA modulates synaptic vesicle recycling. J Biol Chem (2007) 1.23
CXXC5 is a novel BMP4-regulated modulator of Wnt signaling in neural stem cells. J Biol Chem (2008) 1.23
Relative tissue expression of homologous torsinB correlates with the neuronal specific importance of DYT1 dystonia-associated torsinA. Hum Mol Genet (2009) 1.22
Galpha(olf) levels are regulated by receptor usage and control dopamine and adenosine action in the striatum. J Neurosci (2001) 1.20
The double-strand RNA-dependent protein kinase PKR plays a significant role in a sustained ER stress-induced apoptosis. FEBS Lett (2007) 1.20
Abnormal striatal and thalamic dopamine neurotransmission: Genotype-related features of dystonia. Neurology (2009) 1.18
TorsinA participates in endoplasmic reticulum-associated degradation. Nat Commun (2011) 1.18
Recessively inherited L-DOPA-responsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase gene. Hum Mol Genet (1995) 1.17
Ciz1 promotes mammalian DNA replication. J Cell Sci (2004) 1.17
Variant ataxia-telangiectasia presenting as primary-appearing dystonia in Canadian Mennonites. Neurology (2012) 1.17
Expression of the early-onset torsion dystonia gene (DYT1) in human brain. Ann Neurol (1998) 1.16
siRNA knock-down of mutant torsinA restores processing through secretory pathway in DYT1 dystonia cells. Hum Mol Genet (2008) 1.15
ERAD and ERAD tuning: disposal of cargo and of ERAD regulators from the mammalian ER. Curr Opin Cell Biol (2011) 1.15
TorsinA and torsion dystonia: Unraveling the architecture of the nuclear envelope. Proc Natl Acad Sci U S A (2004) 1.14
Cell-autonomous alteration of dopaminergic transmission by wild type and mutant (DeltaE) TorsinA in transgenic mice. Neurobiol Dis (2010) 1.14
The early-onset torsion dystonia-associated protein, torsinA, is a homeostatic regulator of endoplasmic reticulum stress response. Hum Mol Genet (2010) 1.13
Developmental expression of rat torsinA transcript and protein. Brain Res Dev Brain Res (2004) 1.13
Genotype-phenotype correlations in THAP1 dystonia: molecular foundations and description of new cases. Parkinsonism Relat Disord (2012) 1.12
Distribution of the mRNAs encoding torsinA and torsinB in the normal adult human brain. Ann Neurol (1999) 1.12
Impaired striatal D2 receptor function leads to enhanced GABA transmission in a mouse model of DYT1 dystonia. Neurobiol Dis (2009) 1.12
The Caenorhabditis elegans polarity gene ooc-5 encodes a Torsin-related protein of the AAA ATPase superfamily. Development (2001) 1.12
Dopamine transmission in DYT1 dystonia: a biochemical and autoradiographical study. Neurology (2002) 1.12
Developmental patterns of torsinA and torsinB expression. Brain Res (2006) 1.12
Structural determinants of specific DNA-recognition by the THAP zinc finger. Nucleic Acids Res (2010) 1.11
GABAergic terminals are required for postsynaptic clustering of dystrophin but not of GABA(A) receptors and gephyrin. J Neurosci (2002) 1.10
DYT6 dystonia: review of the literature and creation of the UMD Locus-Specific Database (LSDB) for mutations in the THAP1 gene. Hum Mutat (2011) 1.08
Cloning and characterization of a novel p21(Cip1/Waf1)-interacting zinc finger protein, ciz1. Biochem Biophys Res Commun (1999) 1.07
Basal ganglia dopamine loss due to defect in purine recycling. Neurobiol Dis (2007) 1.06
A Drosophila model of early onset torsion dystonia suggests impairment in TGF-beta signaling. Hum Mol Genet (2004) 1.06
Pathophysiology of antipsychotic drug-induced movement disorders. J Clin Psychiatry (2004) 1.06
ATM and ATR pathways signal alternative splicing of Drosophila TAF1 pre-mRNA in response to DNA damage. Mol Cell Biol (2006) 1.05
Striatal dopamine in early-onset primary torsion dystonia with the DYT1 mutation. Neurology (2000) 1.05
C-terminal domains deliver the DNA replication factor Ciz1 to the nuclear matrix. J Cell Sci (2007) 1.04
Homozygous THAP1 mutations as cause of early-onset generalized dystonia. Mov Disord (2011) 1.03
Molecular pathways in dystonia. Neurobiol Dis (2010) 1.02
Mutant torsinA, which causes early-onset primary torsion dystonia, is redistributed to membranous structures enriched in vesicular monoamine transporter in cultured human SH-SY5Y cells. Mov Disord (2005) 1.00
E2F1 works as a cell cycle suppressor in mature neurons. J Neurosci (2007) 1.00
Histone H3 phosphorylation is under the opposite tonic control of dopamine D2 and adenosine A2A receptors in striatopallidal neurons. Neuropsychopharmacology (2009) 0.98
Abnormal plasticity in dystonia: Disruption of synaptic homeostasis. Neurobiol Dis (2010) 0.98
Functional imaging in hereditary dystonia. Eur J Neurol (2010) 0.98
Functional analysis of dopaminergic systems in a DYT1 knock-in mouse model of dystonia. Neurobiol Dis (2012) 0.97
Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope. Neuron (2005) 3.75
Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms. Lancet Neurol (2008) 3.49
Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome. Nat Genet (2004) 2.50
Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science (2006) 2.49
A critical evaluation of the Braak staging scheme for Parkinson's disease. Ann Neurol (2008) 2.44
Mislocalization to the nuclear envelope: an effect of the dystonia-causing torsinA mutation. Proc Natl Acad Sci U S A (2004) 2.19
The AAA+ protein torsinA interacts with a conserved domain present in LAP1 and a novel ER protein. J Cell Biol (2005) 1.89
Patient-based outcomes of cervical dystonia: a review of rating scales. Mov Disord (2004) 1.59
Primary dystonia: molecules and mechanisms. Nat Rev Neurol (2009) 1.51
A molecular mechanism underlying the neural-specific defect in torsinA mutant mice. Proc Natl Acad Sci U S A (2010) 1.51
The Parkinson disease protein leucine-rich repeat kinase 2 transduces death signals via Fas-associated protein with death domain and caspase-8 in a cellular model of neurodegeneration. J Neurosci (2009) 1.42
Late onset ataxia: MSA-C or SCA 17? A gene penetrance dilemma. Mov Disord (2013) 1.39
Perrault syndrome is caused by recessive mutations in CLPP, encoding a mitochondrial ATP-dependent chambered protease. Am J Hum Genet (2013) 1.37
Cerebellothalamocortical pathway abnormalities in torsinA DYT1 knock-in mice. Proc Natl Acad Sci U S A (2011) 1.33
A novel RAB7 mutation associated with ulcero-mutilating neuropathy. Ann Neurol (2004) 1.33
The WD40 domain is required for LRRK2 neurotoxicity. PLoS One (2009) 1.32
TorsinA hypofunction causes abnormal twisting movements and sensorimotor circuit neurodegeneration. J Clin Invest (2014) 1.28
Thymidine kinase 2 (H126N) knockin mice show the essential role of balanced deoxynucleotide pools for mitochondrial DNA maintenance. Hum Mol Genet (2008) 1.26
The dystonia-associated protein torsinA modulates synaptic vesicle recycling. J Biol Chem (2007) 1.23
Spastin and microtubules: Functions in health and disease. J Neurosci Res (2007) 1.22
Dystonia rating scales: critique and recommendations. Mov Disord (2013) 1.17
Human spastin has multiple microtubule-related functions. J Neurochem (2005) 1.16
Regulation of alpha-synuclein by bFGF in cultured ventral midbrain dopaminergic neurons. J Neurochem (2003) 1.14
alpha-synuclein is required for the fibrillar nature of ubiquitinated inclusions induced by proteasomal inhibition in primary neurons. J Biol Chem (2004) 1.13
A clinical, genetic and biochemical study of SPG7 mutations in hereditary spastic paraplegia. Brain (2004) 1.11
LRRK2 Parkinson disease mutations enhance its microtubule association. Hum Mol Genet (2011) 1.08
Lamina-associated polypeptide-1 interacts with the muscular dystrophy protein emerin and is essential for skeletal muscle maintenance. Dev Cell (2013) 1.07
SGCE mutations cause psychiatric disorders: clinical and genetic characterization. Brain (2013) 1.05
Impact of cervical dystonia on quality of life. Mov Disord (2002) 1.05
Genetic and clinical heterogeneity in paroxysmal kinesigenic dyskinesia: evidence for a third EKD gene. Mov Disord (2002) 1.05
TorsinA and dystonia: from nuclear envelope to synapse. J Neurochem (2009) 1.04
A systematic evaluation of integration free reprogramming methods for deriving clinically relevant patient specific induced pluripotent stem (iPS) cells. PLoS One (2013) 1.03
Loss of phosphatidylinositol 4-kinase 2alpha activity causes late onset degeneration of spinal cord axons. Proc Natl Acad Sci U S A (2009) 1.01
Mutant torsinA, which causes early-onset primary torsion dystonia, is redistributed to membranous structures enriched in vesicular monoamine transporter in cultured human SH-SY5Y cells. Mov Disord (2005) 1.00
Genetic background modulates the phenotype of a mouse model of DYT1 dystonia. PLoS One (2012) 0.95
SGCE and myoclonus dystonia: motor characteristics, diagnostic criteria and clinical predictors of genotype. J Neurol (2014) 0.95
What sample sizes for reliability and validity studies in neurology? J Neurol (2012) 0.95
No association with common Caucasian genotypes in exons 8, 13 and 14 of the human cytoplasmic dynein heavy chain gene (DNCHC1) and familial motor neuron disorders. Amyotroph Lateral Scler Other Motor Neuron Disord (2003) 0.93
CSN complex controls the stability of selected synaptic proteins via a torsinA-dependent process. EMBO J (2010) 0.90
Plasma melatonin is reduced in Huntington's disease. Mov Disord (2014) 0.89
A novel NIPA1 mutation associated with a pure form of autosomal dominant hereditary spastic paraplegia. Neurogenetics (2005) 0.89
The cervical dystonia impact profile (CDIP-58): can a Rasch developed patient reported outcome measure satisfy traditional psychometric criteria? Health Qual Life Outcomes (2008) 0.87
Leucine-rich repeat kinase 2 for beginners: six key questions. Cold Spring Harb Perspect Med (2012) 0.86
The nuclear envelope: an intriguing focal point for neurogenetic disease. Neurotherapeutics (2014) 0.86
Characterization of a novel TYMP splice site mutation associated with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). Neuromuscul Disord (2008) 0.85
Three novel spastin (SPG4) mutations in families with autosomal dominant hereditary spastic paraplegia. J Neurol Sci (2002) 0.83
Analysis of the epsilon-sarcoglycan gene in familial and sporadic myoclonus-dystonia: evidence for genetic heterogeneity. Mov Disord (2003) 0.80
Parkinson syndrome. Heterogeneity of etiology; heterogeneity of pathogenesis? Neurology (2012) 0.80
The nuclear envelope protein, LAP1B, is a novel protein phosphatase 1 substrate. PLoS One (2013) 0.80
Myoclonus-dystonia syndrome with severe depression is caused by an exon-skipping mutation in the epsilon-sarcoglycan gene. Mov Disord (2007) 0.80
Evidence-based guidelines for using the Short Form 36 in cervical dystonia. Mov Disord (2007) 0.78
Targeted disruption of neuronal 19S proteasome subunits induces the formation of ubiquitinated inclusions in the absence of cell death. J Neurochem (2011) 0.78
Recent advances in the molecular pathogenesis of dystonia-plus syndromes and heredodegenerative dystonias. Curr Neuropharmacol (2013) 0.78
Focal dystonia is associated with a polymorphism of the dopamine D5 receptor gene. Adv Neurol (2004) 0.77
Screening for mutations in the phosphatidylinositol 4-kinase 2-alpha gene in autosomal recessive hereditary spastic paraplegia. Amyotroph Lateral Scler (2010) 0.77
Lack of alpha-synuclein does not alter apoptosis of neonatal catecholaminergic neurons. Eur J Neurosci (2004) 0.76
Magic shotgun for Parkinson's disease? Brain (2014) 0.75
Paroxysmal exercise-induced dyskinesia of the hands. Mov Disord (2012) 0.75
Clinical diagnosis of cervical dystonia. Eur J Gen Pract (2004) 0.75
Nomenclature of genetic movement disorders: Recommendations of the International Parkinson and Movement Disorder Society task force. Mov Disord (2017) 0.75